Affordable Access

Publisher Website

Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression

Authors
Journal
Psychoneuroendocrinology
0306-4530
Publisher
Elsevier
Publication Date
Volume
31
Issue
10
Identifiers
DOI: 10.1016/j.psyneuen.2006.08.001
Keywords
  • Major Depression
  • Prediction
  • Dex/Crh Test
  • Glucocorticoid Receptor
  • Polymorphism
  • Paroxetine
Disciplines
  • Biology

Abstract

Summary Objective We investigated whether treatment response is predicted by hypothalamus–pituitary–adrenal (HPA) axis parameters, or by genetic polymorphisms in the glucocorticoid receptor (GR), that regulates its feedback. Methods Ninety-eight outpatients completed 8 weeks of paroxetine treatment. Treatment response was defined as a 50% decrease in Hamilton Rating Scale for depression (HRSD) ratings. At baseline, 24 h urinary cortisol excretion, and cortisol and ACTH concentrations in a DEX/CRH test were measured. The presence of polymorphisms in the GR DNA sequence (BclI, ER22/23EK, N363S) was determined. Prediction of treatment response was analysed by calculating response rates per tertile of an HPA-axis parameter and per GR genotype. Results The response rate in the high ACTH tertile was significantly lower as compared to the intermediate tertile, but not compared to the low tertile (response rates from high to low tertile: 33%, 67% and 42%). Carriers of the BclI polymorphism had higher ACTH values than non-carriers (baseline ACTH: 3 versus 5 ng/l, p=0.02) and showed a trend towards lower decrease of HRSD rates than non-carriers (HRSD decrease: 8 versus 11, respectively, p=0.07). In a subgroup of BclI carriers, patients in the high ACTH tertile had a lower decrease in HRSD and lower response rates than patients in the low ACTH tertiles (HRSD decrease from high to low tertile: 5, 9 and 11, p < 0.01 ). Conclusion The results suggest that hyperactivity of the HPA-axis predict worse treatment outcome. The BclI polymorphism explains, in part, DEX/CRH test results and tends to be associated with worse treatment outcome.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Prediction of treatment response by HPA-axis and g...

on Psychoneuroendocrinology November 2006

The impact of treatment on HPA axis activity in un...

on Journal of Psychiatric Researc... Jan 01, 2010

Genetic variability at HPA axis in major depressio...

on Journal of Affective Disorders Jan 01, 2007

Genetic variability at HPA axis in major depressio...

on Journal of affective disorders December 2007
More articles like this..